Search Results - Antoszyk An

Refine Results
  1. 1
    Linkage of atypical vitelliform macular dystrophy (VMD-1) to the soluble glutamate pyruvate transaminase (GPT1) locus.

    Linkage of atypical vitelliform macular dystrophy (VMD-1) to the soluble glutamate pyruvate transaminase (GPT1) locus. by Ferrell, R E, Hittner, H M, Antoszyk, J H

    Published 1983
    Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Night Vision Symptoms and Progression of Age-related Macular Degeneration (AMD) in the Complications of AMD Prevention Trial

    Night Vision Symptoms and Progression of Age-related Macular Degeneration (AMD) in the Complications of AMD Prevention Trial by Ying, Gui-shuang, Maguire, Maureen, Liu, Chengcheng, Antoszyk, Andrew

    Published 2008
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    “Pacman” invasion of the retina: Two cases of ophthalmomyiasis interna posterior

    “Pacman” invasion of the retina: Two cases of ophthalmomyiasis interna posterior by Punjabi, Omar S., Browning, David J., Clark, Loraine, Antoszyk, Andrew N.

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Anterior segment mesenchymal dysgenesis: Probable linkage to the MNS blood group on chromosome 4

    Anterior segment mesenchymal dysgenesis: Probable linkage to the MNS blood group on chromosome 4 by Ferrell, Robert E., Hittner, Helen M., Kretzer, Frank L., Antoszyk, James H.

    Published 1982
    Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Contact focusing multimodal microprobes for ultraprecise laser tissue surgery

    Contact focusing multimodal microprobes for ultraprecise laser tissue surgery by Darafsheh, Arash, Fardad, Amir, Fried, Nathaniel M., Antoszyk, Andrew N., Ying, Howard S., Astratov, Vasily N.

    Published 2011
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Answer to April 2018 Photo Quiz

    Answer to April 2018 Photo Quiz by Long, Elizabeth B., Patel, Niraj C., Sautter, Robert L., Antoszyk, James, Dollar, James D., Rupar, David

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Photo Quiz: A 9-Year-Old Girl with Eye Swelling and Drainage

    Photo Quiz: A 9-Year-Old Girl with Eye Swelling and Drainage by Long, Elizabeth B., Patel, Niraj C., Sautter, Robert L., Antoszyk, James, Dollar, James D., Rupar, David

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    SCORE Study Report 7: Incidence of Intravitreal Silicone Oil Droplets Associated With Staked-on Versus Luer Cone Syringe Design

    SCORE Study Report 7: Incidence of Intravitreal Silicone Oil Droplets Associated With Staked-on Versus Luer Cone Syringe Design by Scott, Ingrid U., Oden, Neal L., VanVeldhuisen, Paul C., Ip, Michael S., Blodi, Barbara A., Antoszyk, Andrew N.

    Published 2009
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    Characterization of novel microsphere chain fiber optic tips for potential use in ophthalmic laser surgery

    Characterization of novel microsphere chain fiber optic tips for potential use in ophthalmic laser surgery by Hutchens, Thomas C., Darafsheh, Arash, Fardad, Amir, Antoszyk, Andrew N., Ying, Howard S., Astratov, Vasily N., Fried, Nathaniel M.

    Published 2012
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    A Randomized Trial Comparing Intravitreal Triamcinolone and Focal/Grid Photocoagulation for Diabetic Macular Edema: Baseline Features

    A Randomized Trial Comparing Intravitreal Triamcinolone and Focal/Grid Photocoagulation for Diabetic Macular Edema: Baseline Features by Ip, Michael S., Bressler, Susan B., Antoszyk, Andrew N., Flaxel, Christina J., Kim, Judy E., Friedman, Scott M., Qin, Haijing

    Published 2008
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    EVALUATION OF FULL-FIELD ELECTRORETINOGRAM REDUCTIONS AFTER OCRIPLASMIN TREATMENT: Results of the OASIS Trial ERG Substudy

    EVALUATION OF FULL-FIELD ELECTRORETINOGRAM REDUCTIONS AFTER OCRIPLASMIN TREATMENT: Results of the OASIS Trial ERG Substudy by Birch, David G., Benz, Matthew S., Miller, Daniel M., Antoszyk, Andrew N., Markoff, Joseph, Kozma, Petra, Meunier, Esmeralda, Sergott, Robert C.

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    SCORE Study Report 3: Study Design and Baseline Characteristics

    SCORE Study Report 3: Study Design and Baseline Characteristics by Ip, Michael S., Oden, Neal L., Scott, Ingrid U., VanVeldhuisen, Paul C., Blodi, Barbara A., Figueroa, Maria, Antoszyk, Andrew, Elman, Michael

    Published 2009
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    Visual acuity outcomes after anti-VEGF treatment for neovascular age-related macular degeneration: AREDS2 Report Number 19

    Visual acuity outcomes after anti-VEGF treatment for neovascular age-related macular degeneration: AREDS2 Report Number 19 by Keenan, Tiarnan D., Vitale, Susan, Agrón, Elvira, Domalpally, Amitha, Antoszyk, Andrew N., Elman, Michael J., Clemons, Traci E., Chew, Emily Y.

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  14. 14
    Observational Study of the Development of Diabetic Macular Edema Following Panretinal (Scatter) Photocoagulation Given in 1 or 4 Sittings

    Observational Study of the Development of Diabetic Macular Edema Following Panretinal (Scatter) Photocoagulation Given in 1 or 4 Sittings by Brucker Aj, Hong Qin, Antoszyk An, Beck Rw, Bressler Nm, Browning DJ, Michael J. Elman, Adam R. Glassman, Gross Jg, Craig Kollman, Wells Ja

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Study Report 4

    Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein... by Scott, Ingrid U., VanVeldhuisen, Paul C., Ip, Michael S., Blodi, Barbara A., Oden, Neal L., King, Jacqueline, Antoszyk, Andrew N., Peters, Mark A., Tolentino, Michael

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  16. 16
    Visual Acuity, Vitreous Hemorrhage, and Other Ocular Outcomes After Vitrectomy vs Aflibercept for Vitreous Hemorrhage Due to Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial

    Visual Acuity, Vitreous Hemorrhage, and Other Ocular Outcomes After Vitrectomy vs Aflibercept for Vitreous Hemorrhage Due to Diabetic Retinopathy: A Secondary Analysis of a Randomi... by Glassman, Adam R., Beaulieu, Wesley T., Maguire, Maureen G., Antoszyk, Andrew N., Chow, Clement C., Elman, Michael J., Jampol, Lee M., Salehi-Had, Hani, Sun, Jennifer K.

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  17. 17
    Phase 1 Study of OPT-302 Inhibition of Vascular Endothelial Growth Factors C and D for Neovascular Age-Related Macular Degeneration

    Phase 1 Study of OPT-302 Inhibition of Vascular Endothelial Growth Factors C and D for Neovascular Age-Related Macular Degeneration by Pravin U. Dugel, David S. Boyer, Andrew N. Antoszyk, Nathan Steinle, Michael P. Varenhorst, Joel Pearlman, Mark C. Gillies, Robert P. Finger, Megan E. Baldwin, Ian M. Leitch

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study)

    Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study) by Glassman, Adam R., Wells, John A., Josic, Kristin, Maguire, Maureen G., Antoszyk, Andrew N., Baker, Carl, Beaulieu, Wesley T., Elman, Michael J., Jampol, Lee M., Sun, Jennifer K.

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  19. 19
    Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study)

    Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study) by Adam R. Glassman, John A. Wells, Kristin Josic, Maureen G. Maguire, Andrew N. Antoszyk, Carl W. Baker, Wesley T. Beaulieu, Michael J. Elman, Lee M. Jampol, Jennifer K. Sun

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy

    Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy by Andrew N. Antoszyk, Adam R. Glassman, Wesley T. Beaulieu, Lee M. Jampol, Chirag Jhaveri, Omar S. Punjabi, Hani Salehi-Had, John A. Wells, Maureen G. Maguire, Cynthia R. Stockdale, Daniel Martín, Jennifer K. Sun

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: